我国科学家在神经疾病治疗领域取得新突破

Core Insights - Researchers in China have revealed the critical role of the formyl peptide receptor 1 (FPR1) pathway in central nervous system inflammation and degenerative diseases, indicating a significant advancement in understanding these conditions [1] - A novel drug molecule has been successfully developed with potential clinical applications, opening new avenues for the treatment of neurological diseases such as multiple sclerosis [1] Group 1 - The study highlights the importance of the FPR1 pathway in the context of central nervous system disorders [1] - The development of a new drug molecule signifies progress in therapeutic options for neurodegenerative diseases [1]